Regentis Biomaterials Files POS AM for Resale of Private Placement Securities

Filing content

The company filed a post-effective amendment to its registration statement for the resale of securities issued in a prior private placement. While the exercise of warrants could yield approximately $8.21 million in proceeds, this filing itself does not raise new capital.